FTC Wants More Info On $4.8B Roche Buy Of Swiss Gene Co.
The Federal Trade Commission wants more information before it decides whether to sign off on Swiss pharmaceutical company Roche's $4.8 billion plan to buy gene therapy company Spark Therapeutics....To view the full article, register now.
Already a subscriber? Click here to view full article